The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Discount to NAV now moved to 9%. Good buying opportunity for a trust with an excellent long-term record.
The stately manager of CGT, Mr Spiller, would tell you that the tortoise wins the long race. I'm not sure, but glad to have a steady plodder in my portfolio to sit alongside the racier gazelles. It offers genuine diversification and arguably better protection against inflation than more speculative bets like gold, crypto and commodities.
@NoelShempsky - still confident in your 800 share call by Christmas or sooner? The narrative all seemed so easy back in May/June.... commodities super cycle, stimulus, economy bouncing back. undersupply, possible inflation - nothing but roses and easy money. The stark reality for the majority of these commodities companies is that they fall and rise with the whim of the Chinese demand. Unfortunately this fund and its constituent shares have still got a way to fall yet to get back to earth - and the balance between predicted supply/demand.
I've been loading up on NEX since the nadir of its share price in September last year, and it's my largest holding now. The drop over the last few months looks very overdone and I'm adding some more. This is not an IAG or SSP that are precariously exposed to international travel, but a well-run and diversified travel company with many long duration contracts and overseas operations. NEX will come out of this crises stronger, and those who had the courage to buy against short-term sentiment will be rewarded (but patience needed).
Did anyone who looked at the update figures/report see anything of concern that might explain this sell-off? Just wondering - it seems more than just a little profit taking as the share price has been trending down for the past couple of weeks. I hope the fact that this is a very well-run company in a structurally growing sector should steady the drop, and eventually return to its excellent long-term track record.
Probably just supply and demand - company prospering and growing, investors wanting to buy in, but shares very tightly held (CEO William McIlroy and family owns half of the business, and senior management a large proportion of the remainder). I wouldn't be surprised if some fund management institutions aren't buying. Long may the upwards trend continue!
The long-term track is excellent, and healthcare should be a safe bet for future returns. I've been holding this since May 2020 and it's been tracking sideways ever since. I'm holding on, but hope for some uplift soon! It's the one laggard in my portfolio.
Liberum have just put out a 'buy' recommendation with a target price of 460p, which may explain the rise.
Some strong rises over the last few days.... are any of the institutions buying into what is a promising long-term growth story? Great presentation from management the other day, looking forward to seeing progress over the next few years towards international expansion.
I'm not pleased either. Whilst this is a nice bump up for traders and short-term holders, we all know that Sumo could be multiple times its current size in a few years. Once again, the lure of easy money has proved irresistible for management, and long-term holders have had a potential multi-bagger cut short.
I've no idea, but the share price rally (almost doubling from the lows) may have got ahead of itself. Based on no real positive news of earnings, other than talk of resilience and a strong platform for future growth. There's a lot to like about this business, and I'd like to buy for the long-term, but the unbroken rally combined with a wide bid/offer spread makes me want to wait for a better entry point.
@CHEQUEMATE - I sympathise..... been there a few times when you invest, the SP drops and it unnerves you about the investment case enough to make you sell out. The markets are very volatile atm. Sumo will be fine though and patience will be rewarded. Hopefully, you'll be able to buy in at a better price if you choose to reinvest. Best of luck.
You should have stayed invested. Sumo is a long-term winner. Admittedly, it's SP may have got ramped up too far in recent months but long-term this is going up - consistently growing revenues at 25% per annum, healthy profit margins and chucking out cash to reinvest. This is only a bit of profit taking and rotation into value stocks. However, this is a short-term game. After a short uplift in these airlines and energy companies, gaming companies like Sumo will keep powering on well after lockdown ends.
Ouch....this is a steep drop. How far is this going to slide? Let's wait for news on rights issue.
I'd be very surprised if JP Morgan are driving these falls. Good video here entitled 'The Search for Great British Companies in the Covid Crisis': https://citywire.co.uk/investment-trust-insider/news/watch-the-search-for-great-british-companies-in-the-covid-crisis/a1386582
Interviews Guy Anderson of the Mercantile Trust (JP Morgan) who mentions they added to their position on NEX. Makes it clear that this is a fundamentally strong and well-run business - although investors should have a holding horizon of at least 3 years for full recovery.
In my opinion, this is one of the best buys on the FTSE right now, and amongst those with the lowest risk vs reward ratio. Don't care about short-term price falls - looking back in a several year's time, this period of peak uncertainty is where the best buying opportunities are!